HKDC1 Is a novel hexokinase involved in Whole-Body glucose use

Anton E. Ludvik, Carolina M. Pusec, Medha Priyadarshini, Anthony R. Angueira, Cong Guo, Amy Lo, Korri S. Hershenhouse, Guang Yu Yang, Xianzhong Ding, Timothy E. Reddy, William L. Lowe, Brian T. Layden

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In a recent genome-wide association study, hexokinase domain-containing protein 1, or HKDC1, was found to be associated with gestational glucose levels during 2-hour glucose tolerance tests at 28 weeks of pregnancy. Because our understanding of the mediators of gestational glucose homeostasis is incomplete, we have generated the first transgenic mouse model to begin to understand the role of HKDC1 in whole-body glucose homeostasis. Interestingly, deletion of both HKDC1 alleles results in in utero embryonic lethality. Thus, in this study, we report the in vivo role of HKDC1 in whole-body glucose homeostasis using a heterozygous-deleted HKDC1 mouse model (HKDC1+/-) as compared with matched wild-type mice. First, we observed no weight, fasting or random glucose, or fasting insulin abnormalities with aging in male and female HKDC1+/- mice. However, during glucose tolerance tests, glucose levels were impaired in both female and male HKDC1+/- mice at 15, 30, and 120 minutes at a later age (28 wk of age). These glucose tolerance differences also existed in the female HKDC1+/- mice at earlier ages but only during pregnancy. And finally, the impaired glucose tolerance in HKDC1+/- mice was likely due to diminished wholebody glucose use, as indicated by the decreased hepatic energy storage and reduced peripheral tissue uptake of glucose in HKDC1+/- mice. Collectively, these data highlight that HKDC1 is needed to maintain whole-body glucose homeostasis during pregnancy but also with aging, possibly through its role in glucose use.

Original languageEnglish (US)
Pages (from-to)3452-3461
Number of pages10
JournalEndocrinology
Volume157
Issue number9
DOIs
StatePublished - Sep 2016

Fingerprint

Hexokinase
Glucose
Homeostasis
Glucose Tolerance Test
Pregnancy
Fasting
Glucose Intolerance
Genome-Wide Association Study
Transgenic Mice
Alleles
Insulin

ASJC Scopus subject areas

  • Endocrinology

Cite this

Ludvik, A. E., Pusec, C. M., Priyadarshini, M., Angueira, A. R., Guo, C., Lo, A., ... Layden, B. T. (2016). HKDC1 Is a novel hexokinase involved in Whole-Body glucose use. Endocrinology, 157(9), 3452-3461. https://doi.org/10.1210/en.2016-1288
Ludvik, Anton E. ; Pusec, Carolina M. ; Priyadarshini, Medha ; Angueira, Anthony R. ; Guo, Cong ; Lo, Amy ; Hershenhouse, Korri S. ; Yang, Guang Yu ; Ding, Xianzhong ; Reddy, Timothy E. ; Lowe, William L. ; Layden, Brian T. / HKDC1 Is a novel hexokinase involved in Whole-Body glucose use. In: Endocrinology. 2016 ; Vol. 157, No. 9. pp. 3452-3461.
@article{05bbf72337644de785cec02542156703,
title = "HKDC1 Is a novel hexokinase involved in Whole-Body glucose use",
abstract = "In a recent genome-wide association study, hexokinase domain-containing protein 1, or HKDC1, was found to be associated with gestational glucose levels during 2-hour glucose tolerance tests at 28 weeks of pregnancy. Because our understanding of the mediators of gestational glucose homeostasis is incomplete, we have generated the first transgenic mouse model to begin to understand the role of HKDC1 in whole-body glucose homeostasis. Interestingly, deletion of both HKDC1 alleles results in in utero embryonic lethality. Thus, in this study, we report the in vivo role of HKDC1 in whole-body glucose homeostasis using a heterozygous-deleted HKDC1 mouse model (HKDC1+/-) as compared with matched wild-type mice. First, we observed no weight, fasting or random glucose, or fasting insulin abnormalities with aging in male and female HKDC1+/- mice. However, during glucose tolerance tests, glucose levels were impaired in both female and male HKDC1+/- mice at 15, 30, and 120 minutes at a later age (28 wk of age). These glucose tolerance differences also existed in the female HKDC1+/- mice at earlier ages but only during pregnancy. And finally, the impaired glucose tolerance in HKDC1+/- mice was likely due to diminished wholebody glucose use, as indicated by the decreased hepatic energy storage and reduced peripheral tissue uptake of glucose in HKDC1+/- mice. Collectively, these data highlight that HKDC1 is needed to maintain whole-body glucose homeostasis during pregnancy but also with aging, possibly through its role in glucose use.",
author = "Ludvik, {Anton E.} and Pusec, {Carolina M.} and Medha Priyadarshini and Angueira, {Anthony R.} and Cong Guo and Amy Lo and Hershenhouse, {Korri S.} and Yang, {Guang Yu} and Xianzhong Ding and Reddy, {Timothy E.} and Lowe, {William L.} and Layden, {Brian T.}",
year = "2016",
month = "9",
doi = "10.1210/en.2016-1288",
language = "English (US)",
volume = "157",
pages = "3452--3461",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

Ludvik, AE, Pusec, CM, Priyadarshini, M, Angueira, AR, Guo, C, Lo, A, Hershenhouse, KS, Yang, GY, Ding, X, Reddy, TE, Lowe, WL & Layden, BT 2016, 'HKDC1 Is a novel hexokinase involved in Whole-Body glucose use', Endocrinology, vol. 157, no. 9, pp. 3452-3461. https://doi.org/10.1210/en.2016-1288

HKDC1 Is a novel hexokinase involved in Whole-Body glucose use. / Ludvik, Anton E.; Pusec, Carolina M.; Priyadarshini, Medha; Angueira, Anthony R.; Guo, Cong; Lo, Amy; Hershenhouse, Korri S.; Yang, Guang Yu; Ding, Xianzhong; Reddy, Timothy E.; Lowe, William L.; Layden, Brian T.

In: Endocrinology, Vol. 157, No. 9, 09.2016, p. 3452-3461.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HKDC1 Is a novel hexokinase involved in Whole-Body glucose use

AU - Ludvik, Anton E.

AU - Pusec, Carolina M.

AU - Priyadarshini, Medha

AU - Angueira, Anthony R.

AU - Guo, Cong

AU - Lo, Amy

AU - Hershenhouse, Korri S.

AU - Yang, Guang Yu

AU - Ding, Xianzhong

AU - Reddy, Timothy E.

AU - Lowe, William L.

AU - Layden, Brian T.

PY - 2016/9

Y1 - 2016/9

N2 - In a recent genome-wide association study, hexokinase domain-containing protein 1, or HKDC1, was found to be associated with gestational glucose levels during 2-hour glucose tolerance tests at 28 weeks of pregnancy. Because our understanding of the mediators of gestational glucose homeostasis is incomplete, we have generated the first transgenic mouse model to begin to understand the role of HKDC1 in whole-body glucose homeostasis. Interestingly, deletion of both HKDC1 alleles results in in utero embryonic lethality. Thus, in this study, we report the in vivo role of HKDC1 in whole-body glucose homeostasis using a heterozygous-deleted HKDC1 mouse model (HKDC1+/-) as compared with matched wild-type mice. First, we observed no weight, fasting or random glucose, or fasting insulin abnormalities with aging in male and female HKDC1+/- mice. However, during glucose tolerance tests, glucose levels were impaired in both female and male HKDC1+/- mice at 15, 30, and 120 minutes at a later age (28 wk of age). These glucose tolerance differences also existed in the female HKDC1+/- mice at earlier ages but only during pregnancy. And finally, the impaired glucose tolerance in HKDC1+/- mice was likely due to diminished wholebody glucose use, as indicated by the decreased hepatic energy storage and reduced peripheral tissue uptake of glucose in HKDC1+/- mice. Collectively, these data highlight that HKDC1 is needed to maintain whole-body glucose homeostasis during pregnancy but also with aging, possibly through its role in glucose use.

AB - In a recent genome-wide association study, hexokinase domain-containing protein 1, or HKDC1, was found to be associated with gestational glucose levels during 2-hour glucose tolerance tests at 28 weeks of pregnancy. Because our understanding of the mediators of gestational glucose homeostasis is incomplete, we have generated the first transgenic mouse model to begin to understand the role of HKDC1 in whole-body glucose homeostasis. Interestingly, deletion of both HKDC1 alleles results in in utero embryonic lethality. Thus, in this study, we report the in vivo role of HKDC1 in whole-body glucose homeostasis using a heterozygous-deleted HKDC1 mouse model (HKDC1+/-) as compared with matched wild-type mice. First, we observed no weight, fasting or random glucose, or fasting insulin abnormalities with aging in male and female HKDC1+/- mice. However, during glucose tolerance tests, glucose levels were impaired in both female and male HKDC1+/- mice at 15, 30, and 120 minutes at a later age (28 wk of age). These glucose tolerance differences also existed in the female HKDC1+/- mice at earlier ages but only during pregnancy. And finally, the impaired glucose tolerance in HKDC1+/- mice was likely due to diminished wholebody glucose use, as indicated by the decreased hepatic energy storage and reduced peripheral tissue uptake of glucose in HKDC1+/- mice. Collectively, these data highlight that HKDC1 is needed to maintain whole-body glucose homeostasis during pregnancy but also with aging, possibly through its role in glucose use.

UR - http://www.scopus.com/inward/record.url?scp=84985914630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985914630&partnerID=8YFLogxK

U2 - 10.1210/en.2016-1288

DO - 10.1210/en.2016-1288

M3 - Article

C2 - 27459389

AN - SCOPUS:84985914630

VL - 157

SP - 3452

EP - 3461

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -

Ludvik AE, Pusec CM, Priyadarshini M, Angueira AR, Guo C, Lo A et al. HKDC1 Is a novel hexokinase involved in Whole-Body glucose use. Endocrinology. 2016 Sep;157(9):3452-3461. https://doi.org/10.1210/en.2016-1288